Companies / Belite Bio, Inc

Belite Bio, Inc

Nasdaq: BLTECIK 1889109SAN DIEGO, CA

Financials

Revenue
Net income$-77.61M
Total debt
Cash$352.93M
Diluted EPS$-2.31
Shares outstanding39.3M

Ownership

39.3M shares outstanding
18.2%Institutions
Ownership
Institutions18.16%7,145,345
Public float81.84%32,194,615

% of common shares outstanding (single-class filing figure). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 9

View all →
Insider% of sharesShares
Chuang Hao-YuanChief Financial Officer · Director
Lin Yu-HsinCEOChief Executive Officer · Director
Lu ItaDirector
Mata Nathan L.Chief Scientific Officer
Scholl Hendrik PeterChief Medical Officer

Institutional holders 74

View all →

Activity

Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).
DateActorActionSecurityValueShares ΔPosition afterImpact
Q1 2026
as of
RA Capital Management, L.P.
13F manager
ExitADR$-69.18M-432K
-100.00%
high
Q1 2026
as of
Perceptive Advisors LLC
13F manager
TrimADR$-41.81M-262K
-63.31%
151,979
0.39% of shares
medium
Q1 2026
as of
Marshall Wace, LLP
13F manager
ExitADR$-30.82M-193K
-100.00%
medium
Q1 2026
as of
Deerfield Management Company, L.P.
13F manager
AddADR$11.19M+70K
+30.02%
304,013
0.77% of shares
medium
Q1 2026
as of
Renaissance Technologies LLC
13F manager
NewADR$8.29M+52K
52,000
0.13% of shares
medium
Q1 2026
as of
TD Asset Management Inc
13F manager
NewADR$5.33M+33K
33,410
0.08% of shares
medium
Q1 2026
as of
BNP Paribas Financial Markets
13F manager
AddADR$4.80M+30K
+1228.64%
32,525
0.08% of shares
low
Q2 2026
as of
Quadrature Capital Ltd
13F manager
ExitADR$-3.97M-25K
-100.00%
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Darwin Global Management, Ltd.Passive13G/A

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
BLTEADREquity07782B104BBG016LJYT18